Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform

Idoven 1903 S.L. · NCT07333547

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
200000
US sites recruiting
1
Study start
February 3, 2026
Record last updated
July 20, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The WILLEM Registry is a large-scale, single-group, observational, registry study to collect continuous clinical evidence of Willem in real-world settings. Cardiovascular diseases are a major problem for public health and healthcare systems. Electrocardiograms (ECGs) are simple tests which increase diagnostic performance and early detection of cardiovascular diseases. However, its interpretation is complex, time consuming for cardiology experts, and entails high costs for healthcare systems. Willem allows AI-based automatic interpretation and its performance has been examined in previous clinical trials, but additional clinical evidence is needed for its integration in real-world clinical settings. This study will collect clinical evidence of Willem performance to detect cardiac abnormalities in ECGs from high-risk cardiac patients admitted to cardiovascular units.

Being studied: Willem AI ECG assessment

Conditions: High-risk Cardiac Patients

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • EC/IRB approval of ICF waiver prior to recruitment; otherwise, signed informed consent form by subject and investigator
  • Age > 18 years-old, with no upper limit
  • Subjects undergoing standard of care electrocardiogram (ECG) of any duration from any hardware device
  • All available, but at least one, legible ECG tracings in raw data format (e.g. DICOM, XML, EDF, JSON, HL7, SCP, WFDB, CSV, etc.)
  • Available subject clinical data associated with the ECG
  • For 12-lead ECGs, a minimum length of 10 seconds at a minimum sample frequency of 250 Hz
  • For ECGs from Holters, wearables, patches, insertable cardiac monitors, telemetries, etc., a minimum length of 30 seconds at a minimum sample frequency of 200 Hz with a lead I / II or its MCL-DII lead approximation
  • For prospective eligibility only:
  • Signed informed consent form, unless previously waived by the EC/IRB
  • Site technical viability for ECG and subject clinical data transfer (e.g. end-to-end integration following interoperability standards such as FHIR, HL7 or DICOM)

Exclusion Criteria

  • Unavailable or suboptimal quality of the raw data from the ECG signal
  • Age \< 18 years-old

Recruiting US locations

  • Vanderbilt University Medical Center

    Nashville, TN 37232

    Site contact: Evan Brittain, MD, MSCI

Study contacts (from the official record)

  • Manuel Marina-Breysse, MD, PhD · +34669752391 · clinical@idoven.ai
All heart & blood pressure studies in Tennessee →
Registry Study for the Evaluation of High-risk Cardiac Patients by… (NCT07333547) | Bored Studies